Form 4: HealthEquity Director McCowan Reports Acquisition of Common Stock

Sentiment:

SEC Form 4 Filing


Director Debra Charlotte McCowan reports acquiring 2,543 shares of HealthEquity, Inc. common stock on July 5, 2024, and now beneficially owns 12,779 shares.

Summary

  • On July 5, 2024, Debra Charlotte McCowan, a director of HealthEquity, Inc. (HQY), acquired 2,543 shares of common stock.
  • The acquisition was made at a price of $0 per share.
  • Following the transaction, McCowan beneficially owns 12,779 shares of HealthEquity, Inc. common stock.
  • The acquired securities include restricted stock units that vest on the earlier of July 5, 2025, or the date of the issuer's next annual stockholder meeting.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing and doesn't inherently convey positive or negative sentiment. It simply reports a transaction.

Positives

  • The director's acquisition of shares could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units vest on the earlier of July 5, 2025, or the date of the issuer's next annual stockholder meeting, indicating a future event that will result in the delivery of shares to the reporting person.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their holdings in the company's stock.

Stakeholder Impact

  • The transaction may have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.

Next Steps

  • Vesting of restricted stock units on the earlier of July 5, 2025, or the date of the issuer's next annual stockholder meeting.

Key Dates

DateDescription
06/26/2023Date of Power of Attorney filing by Ms. McCowan with the SEC.
07/05/2024Date of the transaction: acquisition of 2,543 shares of common stock.
07/05/2025Vesting date for restricted stock units, or the date of the issuer's next annual stockholder meeting, whichever is earlier.
07/09/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.